Viral Vector Manufacturing Global Market Report 2026
상품코드:1957919
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이러스 벡터 제조 시장 규모는 최근 급성장하고 있습니다. 2025년 82억 6,000만 달러에서 2026년에는 99억 달러에 이르고, CAGR19.9%의 성장이 전망됩니다. 지난 몇 년간의 성장 요인으로는 제조 능력의 한계, 높은 생산 비용, 전통적인 유전자 도입 방식에 대한 의존도, 규제 장벽, 공급망의 파편화 등을 들 수 있습니다.
바이러스 벡터 제조 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 213억 1,000만 달러에 이르고, CAGR은 21.1%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 유전자 및 세포치료제 수요 증가, 바이러스 벡터 기술 발전, 연구개발 투자 증가, 위탁생산기관(CMO) 확대, 맞춤의료 도입 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 유전자 치료의 혁신, 바이러스 벡터의 안전성 최적화, 확장 가능한 제조 공정, 규제 준수 강화, 고도의 업스트림 및 다운스트림 공정 등이 있습니다.
암과 감염성 질환의 유병률 증가는 향후 몇 년 동안 바이러스 벡터 제조 시장의 성장을 가속할 것으로 예측됩니다. 감염성 질환은 바이러스 또는 그 독성 대사 산물이 감염된 사람, 동물 또는 물체와의 접촉을 통해 감염된 숙주에게 전파되는 질병을 말합니다. 암은 비정상적인 세포가 통제할 수 없을 정도로 증식하여 인접 조직으로 침윤하고 다른 장기로 전이되는 다양한 질환군입니다. 바이러스 벡터는 체내 항암 면역반응을 유도하는 종양 항원 생산에 사용되며, 다양한 감염성 질환의 비임상 및 임상시험에서 백신 플랫폼으로 활용되고 있습니다. 예를 들어, 2024년 7월 호주 보건 복지 연구소가 발표한 자료에 따르면, 호주 내 암 진단 건수는 2022년 16,570건에서 2023년 16만 4,694건으로 증가해 매년 큰 폭 증가 추세를 보이고 있습니다. 또한, 2024년 8월 영국 보건안전청은 2023년 영국 내 홍역 발생 건수가 368건이라고 보고했습니다. 이는 2022년 53건 대비 약 7배 증가한 것으로, 감염증의 확산이 두드러지게 나타나고 있음을 알 수 있습니다. 그 결과, 암 및 감염성 질환의 발생률 증가가 바이러스 벡터 제조 시장의 성장을 가속하고 있습니다.
바이러스 벡터 제조 시장의 주요 기업들은 효율적인 바이러스 벡터 생산에 특화된 첨단 플랫폼에 집중하고 있습니다. 바이러스 벡터 플랫폼은 유전자 치료, 백신 제조 등의 용도를 위한 벡터의 개발 및 가공을 최적화하는 통합 시스템입니다. 예를 들어, 2023년 5월 미국 기반의 세계 바이오의약품 CDMO인 AGC바이오로직스는 세포 및 유전자 치료 프로그램을 위한 유연하고 신속한 벡터 개발을 제공하는 'BravoAAV'와 'ProntoLVV' 플랫폼을 발표하였습니다. 이러한 플랫폼은 세계 규제 대응 및 공급 네트워크와 자체 플라즈미드 DNA 서비스를 기반으로 GMP 준수 제품을 9개월 이내에 납품할 수 있습니다. 맞춤형 공정, 템플릿화된 재료 전략, 사전 인증된 분석 방법을 통해 효율적인 유전자 치료 및 백신 생산에 대한 수요 증가에 대응함으로써 2035년까지 55억 달러 규모로 예상되는 바이러스 벡터 제조 시장에 크게 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Viral vector manufacturing involves producing viral vectors, which are tools used to deliver genetic material into cells. Viral vectors enable gene transfer, allowing specific cell types or tissues to express therapeutic genes.
The main types of viral vector manufacturing include adenoviral vectors, adeno-associated viral vectors, lentiviral vectors, retroviral vectors, and others. Adenoviral vectors are double-stranded DNA vectors that are non-enveloped. These vectors are applied in the treatment of cancer, genetic disorders, infectious diseases, and more, using workflows such as upstream and downstream processing. Their applications include gene and cell therapy development, vaccine development, biopharmaceutical and pharmaceutical research, and biomedical studies, and they are utilized by research organizations, biotechnology and pharmaceutical companies, and other institutions.
Tariffs have impacted the viral vector manufacturing market by increasing costs for importing raw materials, bioreactors, and specialized lab equipment, creating challenges for manufacturers in meeting production demands. The most affected segments include upstream and downstream processing equipment, particularly in regions like North America and Europe that rely on imports from Asia-Pacific hubs. Despite these challenges, tariffs have encouraged local manufacturing and investment in domestic production facilities, which could strengthen supply chain resilience and reduce long-term dependency on foreign suppliers.
The viral vector manufacturing market research report is one of a series of new reports from The Business Research Company that provides viral vector manufacturing market statistics, including viral vector manufacturing industry global market size, regional shares, competitors with a viral vector manufacturing market share, detailed viral vector manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector manufacturing industry. This viral vector manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral vector manufacturing market size has grown rapidly in recent years. It will grow from $8.26 billion in 2025 to $9.9 billion in 2026 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to limited manufacturing capacity, high production cost, reliance on traditional gene delivery methods, regulatory barriers, fragmented supply chains.
The viral vector manufacturing market size is expected to see exponential growth in the next few years. It will grow to $21.31 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to growing demand for gene and cell therapies, advancements in viral vector technology, increased R&D investments, expansion of contract manufacturing organizations, rising adoption of personalized medicine. Major trends in the forecast period include gene therapy innovation, viral vector safety optimization, scalable manufacturing processes, regulatory compliance enhancement, advanced upstream and downstream processing.
The rising prevalence of cancer and infectious diseases is expected to drive the growth of the viral vector manufacturing market in the coming years. Infectious diseases are conditions caused by viruses or their toxic byproducts, transmitted to susceptible hosts through contact with infected people, animals, or objects. Cancer comprises a wide range of illnesses in which abnormal cells grow uncontrollably, invade neighboring tissues, and spread to other organs. Viral vectors are used to produce tumor antigens that trigger the body's anticancer immune response and have served as vaccine platforms in preclinical and clinical trials for various infectious diseases. For instance, in July 2024, the Australian Institute of Health and Welfare reported that cancer diagnoses in Australia rose from 160,570 in 2022 to 164,694 in 2023, reflecting a significant yearly increase. Additionally, in August 2024, the UK Health Security Agency reported 368 measles cases in England in 2023, a nearly sevenfold rise from 53 cases in 2022, highlighting the growing prevalence of infectious diseases. Consequently, the increasing incidence of cancer and infectious diseases is fueling the viral vector manufacturing market.
Key companies in the viral vector manufacturing market are focusing on advanced platforms tailored for efficient viral vector production. Viral vector platforms are integrated systems designed to optimize the development and processing of vectors for applications such as gene therapy and vaccine production. For example, in May 2023, AGC Biologics, a US-based global biopharmaceutical CDMO, launched the BravoAAV and ProntoLVV platforms to provide flexible and accelerated vector development for cell and gene therapy programs. These platforms enable GMP-compliant product delivery within nine months, supported by a global regulatory and supply network and in-house plasmid DNA services. With customizable processes, templated material strategies, and prequalified analytical methods, these platforms significantly contribute to the projected $5.5 billion viral vector manufacturing market by 2035 by meeting rising demand for efficient gene therapy and vaccine production.
In January 2024, Oxford Biomedica Plc, a UK-based biotechnology company, acquired ABL Europe from Institut Merieux for $16 million (15 million euros). This acquisition provides Oxford Biomedica with manufacturing facilities in Lyon and Strasbourg, France, expanding its multi-viral vector CDMO capabilities across six sites in the EU, U.S., and U.K. ABL Europe is a France-based CDMO specializing in viral vector manufacturing services.
North America was the largest region in the viral vector manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the viral vector manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector manufacturing market includes revenues earned by entities through the production, packaging, and labeling of viral vector vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses viral vector manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral vector manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector manufacturing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Adenoviral Vectors; Adeno-Associated Viral Vectors; Lentiviral Vectors; Retroviral Vectors; Other Types
2) By Disease: Cancer; Genetic Disorders; Infectious Diseases; Other Diseases
3) By Workflow: Upstream Processing; Downstream Processing
4) By Application: Gene And Cell Therapy Development; Vaccine Development; Biopharmaceutical And Pharmaceutical Discovery; Biomedical Research
5) By End-User: Research Organizations; Biotech And Pharmaceutical Companies; Other End Users
Subsegments:
1) By Adenoviral Vectors: Serotype 5; Serotype 2; Serotype 26
2) By Adeno-Associated Viral Vectors: AAV2; AAV5; AAV8; AAV9; Others
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Gene Therapy Innovation
4.2.2 Viral Vector Safety Optimization
4.2.3 Scalable Manufacturing Processes
4.2.4 Regulatory Compliance Enhancement
4.2.5 Advanced Upstream And Downstream Processing
5. Viral Vector Manufacturing Market Analysis Of End Use Industries
5.1 Research Organizations
5.2 Biotech Companies
5.3 Pharmaceutical Companies
5.4 Academic Institutions
5.5 Contract Manufacturing Organizations
6. Viral Vector Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Viral Vector Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Viral Vector Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Viral Vector Manufacturing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Viral Vector Manufacturing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Viral Vector Manufacturing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Viral Vector Manufacturing Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Viral Vector Manufacturing Market Segmentation
9.1. Global Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.2. Global Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cancer, Genetic Disorders, Infectious Diseases, Other Diseases
9.3. Global Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Upstream Processing, Downstream Processing
9.4. Global Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research
9.5. Global Viral Vector Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Research Organizations, Biotech And Pharmaceutical Companies, Other End Users
9.6. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Serotype 5, Serotype 2, Serotype 26
9.7. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
AAV2, AAV5, AAV8, AAV9, Others
9.8. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.10. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Viral Vector Manufacturing Market
12.1. China Viral Vector Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Viral Vector Manufacturing Market
13.1. India Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Viral Vector Manufacturing Market
14.1. Japan Viral Vector Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Viral Vector Manufacturing Market
15.1. Australia Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Viral Vector Manufacturing Market
16.1. Indonesia Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Viral Vector Manufacturing Market
17.1. South Korea Viral Vector Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Viral Vector Manufacturing Market
19.1. South East Asia Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Viral Vector Manufacturing Market
20.1. Western Europe Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Viral Vector Manufacturing Market
21.1. UK Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Viral Vector Manufacturing Market
22.1. Germany Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Viral Vector Manufacturing Market
23.1. France Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Viral Vector Manufacturing Market
24.1. Italy Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Viral Vector Manufacturing Market
25.1. Spain Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Viral Vector Manufacturing Market
26.1. Eastern Europe Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Viral Vector Manufacturing Market
27.1. Russia Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Viral Vector Manufacturing Market
28.1. North America Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Viral Vector Manufacturing Market
29.1. USA Viral Vector Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Viral Vector Manufacturing Market
31.1. South America Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Viral Vector Manufacturing Market
32.1. Brazil Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Viral Vector Manufacturing Market
33.1. Middle East Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Viral Vector Manufacturing Market
34.1. Africa Viral Vector Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Viral Vector Manufacturing Market, Segmentation By Type, Segmentation By Disease, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Viral Vector Manufacturing Market Regulatory and Investment Landscape
36. Viral Vector Manufacturing Market Competitive Landscape And Company Profiles
